GLEN BURNIE, Md., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Glen Burnie Bancorp (“Company”) (OTCQX: GLBZ), the bank holding company for The Bank of Glen Burnie (“Bank”), announced today that current board member and local business leader, Jay Baldwin, has assumed the role of Chair of the Board of Directors effective immediately. Baldwin succeeds John “Jack” E. Demyan who announced his retirement at the February 19, 2026, meeting of the Glen Burnie Bancorp Board of Directors. Demyan retires after serving as Chair si ...

Kaldvik AS will publish its Q4 2025 quarterly update on 25 February 2026 at 07:00 CET. A webcast presentation of the Q4 2025 quarterly update will be held at 10:00 CET (09:00 Icelandic time) the same day. CEO Vidar Aspehaug and CFO Hjalti Hvítklett will present the Company’s results. The session will be held in English and conducted online. A Q&A session will follow the presentation. The webcast can be accessed via the following link: www.kaldvik.is/live Kaldvik AS publishes full financial statements semi-a ...

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA. Attachment Notification of trade_skjema - Magnus Tolleshaug ...

Nanterre, 20 February 2026 VINCI enters into exclusive negotiations with the French government for the concession of the future A154 and A120 motorway link A major motorway project, spanning nearly 100 km, to enable traffic to bypass the Greater Paris area to the westA 35-year concession agreement, due to be signed in autumn 2026A project leveraging synergy between VINCI Concessions and VINCI Construction High environmental performance standards throughout the programme VINCI, through the consortium AREL, ...

Did you buy RARE common stock between August 3, 2023, and December 26, 2025? Affected Ultragenyx Pharmaceutical Inc. Investor Summary Who: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)What: Securities fraud class action lawsuit filedClass Period: August 3, 2023, through December 26, 2025Deadline to seek lead plaintiff status: April 6, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s drug, setrusumabInvestor action: Contact Kessler Topaz Meltzer & Check, LLP (www. ...

HOUSTON and LONDON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a leader in the global chemical industry, today announced that Agustin Izquierdo, executive vice president and chief financial officer, will participate in a fireside chat at the 2026 Bank of America Global Agriculture and Materials Conference in Fort Lauderdale, Fla., on Thursday, February 26, 2026, at 9:45 a.m. EST. Webcast and Presentation Slides AccessA live webcast can be accessed at the time of the event at https://inv ...

HOUSTON and LONDON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a leader in the global chemical industry, today announced that Agustin Izquierdo, executive vice president and chief financial officer, will participate in a fireside chat at the 2026 Bank of America Global Agriculture and Materials Conference in Fort Lauderdale, Fla., on Thursday, February 26, 2026, at 9:45 a.m. EST. Webcast and Presentation Slides AccessA live webcast can be accessed at the time of the event at https://inv ...

Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V. Investor Summary Who: uniQure N.V. (NASDAQ: QURE)What: Securities fraud class action lawsuit filedClass Period: September 24, 2025, and October 31, 2025Deadline to Seek Lead Plaintiff Status: April 13, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s Huntington’s disease gene therapy drug.Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.c ...

PRESS RELEASE KLÉPIERRE ANNOUNCESCHANGES TO ITSSUPERVISORY BOARD Paris — February 20, 2026 Klépierre announces that Mr. David Simon has concluded his tenure as Chairman and member of the Supervisory Board. The Supervisory Board and Executive Board extend their sincere appreciation to Mr. Simon for his exceptional leadership and strategic insight during his fourteen years at the helm of the Supervisory Board. Effective immediately, the Vice-Chairwoman will serve as interim Chair of the Supervisory Board, whi ...

LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com. Kynd ...